Detection of Pulmonary Fibrosis with a Collagen-Mimetic Peptide.

Abstract

Idiopathic pulmonary fibrosis (IPF) is a disease of unknown etiology that is characterized by excessive deposition and abnormal remodeling of collagen. IPF has a mean survival time of only 2-5 years from diagnosis, creating a need to detect IPF at an earlier stage when treatments might be more effective. We sought to develop a minimally invasive probe that could detect molecular changes in IPF-associated collagen. Here, we describe the design, synthesis, and performance of [68Ga]Ga·DOTA-CMP, which comprises a positron-emitting radioisotope linked to a collagen-mimetic peptide (CMP). This peptide mimics the natural structure of collagen and detects irregular collagen matrices by annealing to damaged collagen triple helices. We assessed the ability of the peptide to detect aberrant lung collagen selectively in a bleomycin-induced mouse model of pulmonary fibrosis using positron emission tomography (PET). [68Ga]Ga·DOTA-CMP PET demonstrated higher and selective uptake in a fibrotic mouse lung compared to controls, minimal background signal in adjacent organs, and rapid clearance via the renal system. These studies suggest that [68Ga]Ga·DOTA-CMP identifies fibrotic lungs and could be useful in the early diagnosis of IPF.

• Authors: Isabella M Borgula, Sergey Shuvaev, Eric Abston, Nicholas J Rotile, Jonah Weigand-Whittier, Iris Y Zhou, Peter Caravan, Ronald T Raines
• Journal: ACS sensors (ACS Sens) Vol. 8 Issue 11 Pg. 4008-4013 (Nov 24 2023) ISSN: 2379-3694 [Electronic] United States
• PMID: 37930825 (Publication Type: Journal Article)

Chemical References

• Gallium Radioisotopes
• Bleomycin
• Collagen

Topics

• Mice
• Animals
• Gallium Radioisotopes (pharmacology)
• Lung (diagnostic imaging)
• Idiopathic Pulmonary Fibrosis (diagnosis, diagnostic imaging)
• Bleomycin (pharmacology)
• Collagen